Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wunderink

Showing results (111-120 of 545) with videos related to

Pageof 55
Sort By:
Infectious Disease Clinics of North America|July 9, 2017
Severe Respiratory Viral Infections: New Evidence and Changing ParadigmsJames M Walter, Richard G Wunderink
Seminars in Respiratory and Critical Care Medicine|February 10, 2009
The role of MRSA in healthcare-associated pneumoniaAnna P Lam, Richard G Wunderink
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated PneumoniaChiagozie I Pickens, Richard G Wunderink
Current Opinion in Infectious Diseases|January 10, 2017
The microbiome in mechanically ventilated patientsYudong Yin, Peter Hountras, Richard G Wunderink
Clinics in Chest Medicine|February 5, 2017
Respiratory Viral and Atypical PneumoniasCharles S Dela Cruz, Richard G Wunderink
Critical Care (London, England)|January 30, 2016
Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Matteo Bassetti, Tobias Welte, Richard G Wunderink
Physics in Medicine and Biology|August 5, 2011
Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distanceY Seppenwoolde, W Wunderink, S R Wunderink-van Veen, et al.
Respirology (Carlton, Vic.)|October 1, 2021
Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go awayGrant Waterer, Chiagozie Ifeoma Pickens, Richard Wunderink
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter studyE Rubinstein, S Cammarata, T Oliphant, et al.
Chest|November 1, 1992
Methodology for clinical investigation of ventilator-associated pneumonia. Epidemiology and therapeutic interventionR G Wunderink, C G Mayhall, C Gibert
Pageof 55

Showing results (111-120 of 545) with videos related to

Sort By:
Pageof 55
Infectious Disease Clinics of North America|July 9, 2017
Severe Respiratory Viral Infections: New Evidence and Changing ParadigmsJames M Walter, Richard G Wunderink
Seminars in Respiratory and Critical Care Medicine|February 10, 2009
The role of MRSA in healthcare-associated pneumoniaAnna P Lam, Richard G Wunderink
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated PneumoniaChiagozie I Pickens, Richard G Wunderink
Current Opinion in Infectious Diseases|January 10, 2017
The microbiome in mechanically ventilated patientsYudong Yin, Peter Hountras, Richard G Wunderink
Clinics in Chest Medicine|February 5, 2017
Respiratory Viral and Atypical PneumoniasCharles S Dela Cruz, Richard G Wunderink
Critical Care (London, England)|January 30, 2016
Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Matteo Bassetti, Tobias Welte, Richard G Wunderink
Physics in Medicine and Biology|August 5, 2011
Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distanceY Seppenwoolde, W Wunderink, S R Wunderink-van Veen, et al.
Respirology (Carlton, Vic.)|October 1, 2021
Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go awayGrant Waterer, Chiagozie Ifeoma Pickens, Richard Wunderink
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter studyE Rubinstein, S Cammarata, T Oliphant, et al.
Chest|November 1, 1992
Methodology for clinical investigation of ventilator-associated pneumonia. Epidemiology and therapeutic interventionR G Wunderink, C G Mayhall, C Gibert
Pageof 55